tradingkey.logo

Nasus Pharma Ltd

NSRX
5.800USD
+0.360+6.62%
交易中 美东报价延迟15分钟
52.55M总市值
亏损市盈率 TTM

Nasus Pharma Ltd

5.800
+0.360+6.62%

关于 Nasus Pharma Ltd 公司

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.

Nasus Pharma Ltd简介

公司代码NSRX
公司名称Nasus Pharma Ltd
上市日期Aug 13, 2025
CEOTeleman (Dan)
员工数量- -
证券类型Ordinary Share
年结日Aug 13
公司地址Yigal Alon 65
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家Israel
邮编- -
电话97237326616
网址https://www.nasuspharma.com
公司代码NSRX
上市日期Aug 13, 2025
CEOTeleman (Dan)

Nasus Pharma Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.90M
+55292.00%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
+42854.00%
Mr. Dan Teleman
Mr. Dan Teleman
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Tair Lapidot, Ph.D.
Dr. Tair Lapidot, Ph.D.
Vice President of Research and Development and Clinical Development
Vice President of Research and Development and Clinical Development
--
--
Galia Temtsin Kryaz
Galia Temtsin Kryaz
Director of CMC and Product Development
Director of CMC and Product Development
--
--
Mr. Oren Elmaliach
Mr. Oren Elmaliach
Director of Finance
Director of Finance
--
--
Mr. Ronnie Hershman
Mr. Ronnie Hershman
Independent Director
Independent Director
--
--
Mr. David Silberman, CPA
Mr. David Silberman, CPA
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Sharon Shacham, Ph.D.
Dr. Sharon Shacham, Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Isaac Israel
Isaac Israel
Independent Director Nominee
Independent Director Nominee
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Udi Gilboa
Mr. Udi Gilboa
Co-Founder, Executive Chairman of the Board of Director
Co-Founder, Executive Chairman of the Board of Director
1.90M
+55292.00%
Dr. Dalia Megiddo
Dr. Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
1.89M
+42854.00%
Mr. Dan Teleman
Mr. Dan Teleman
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Tair Lapidot, Ph.D.
Dr. Tair Lapidot, Ph.D.
Vice President of Research and Development and Clinical Development
Vice President of Research and Development and Clinical Development
--
--
Galia Temtsin Kryaz
Galia Temtsin Kryaz
Director of CMC and Product Development
Director of CMC and Product Development
--
--
Mr. Oren Elmaliach
Mr. Oren Elmaliach
Director of Finance
Director of Finance
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Gilboa (Udi)
21.09%
Megiddo (Dalia)
20.96%
Hershman Holdings L.L.C.
9.89%
Capital Point Ltd
6.38%
Phoenix Solutions Ltd
4.76%
其他
36.92%
持股股东
持股股东
占比
Gilboa (Udi)
21.09%
Megiddo (Dalia)
20.96%
Hershman Holdings L.L.C.
9.89%
Capital Point Ltd
6.38%
Phoenix Solutions Ltd
4.76%
其他
36.92%
股东类型
持股股东
占比
Individual Investor
43.95%
Corporation
21.03%
Investment Advisor
0.03%
其他
34.99%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
2
3.24K
0.00%
--
2025Q4
2
2.38K
0.03%
+1.14K
2025Q3
7
5.35M
59.33%
+5.35M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Gilboa (Udi)
1.90M
21.09%
+55.29K
+3.00%
Sep 30, 2025
Megiddo (Dalia)
1.89M
20.96%
+42.85K
+2.32%
Sep 30, 2025
Hershman Holdings L.L.C.
891.19K
9.89%
+414.18K
+86.83%
Sep 30, 2025
Capital Point Ltd
575.13K
6.38%
+575.13K
--
Aug 14, 2025
Phoenix Solutions Ltd
429.31K
4.76%
--
--
Sep 30, 2025
Krayz (Galia Temtsin)
171.72K
1.91%
+171.72K
--
Aug 12, 2025
Morgan Stanley Smith Barney LLC
2.00K
0.02%
+2.00K
--
Sep 30, 2025
UBS Financial Services, Inc.
1.24K
0.01%
+1.24K
--
Sep 30, 2025
Lapidot (Tair Ph.D.)
10.00
0%
+10.00
--
Aug 12, 2025

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI